Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
BMC Pulmonary Medicine|July 22, 2021
Exposure-safety analyses of nintedanib in patients with chronic fibrosing interstitial lung diseaseUlrike Schmid, Benjamin Weber, Celine Sarr, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 6, 2026
Risks encountered when not adjusting for diurnal variation and food effect in QTcF analysis based on phase I dataMaddlie Bardol, Andrea Henrich, Celine Sarr, et al.BMC Cancer|July 25, 2012
Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trialAndrew Stein, Wenping Wang, Alison A Carter, et al.Investigational New Drugs|March 22, 2014
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumorsJordi Rodon, Irene Braña, Lillian L Siu, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 6, 2026
Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning frameworkNour Chtiba, Sihem Ait-Oudhia, Sonia Khier, et al.Pageof 1